BlackStone Discovery Expands Hatch-Waxman Expertise Under Parkash Khatri
Pharma-specialized review attorneys and proprietary redaction technology LineOut continue to deliver superior results.
July 10, 2018
Silicon Valley, CA – BlackStone Discovery, the premier legal technology and consulting provider, is taking its Hatch-Waxman expertise to a new level with the expansion of a team focused solely on providing superior value to brand and generic pharmaceutical clients around the world. The move is part of BlackStone’s continued growth and expanding global presence. Director of Global Discovery Services, Parkash Khatri, leads the division comprised of attorney reviewers and project managers with deep experience in the Hatch-Waxman field.
Khatri, a longtime veteran in the Hatch-Waxman and eDiscovery space, started the division to help pharmaceutical companies and litigators combat the rising costs of Hatch-Waxman litigation. In parallel, Khatri’s team has created The Hatch-Waxman Playbook: A Comprehensive Guide to Pharma Document Review to assist all legal and review teams in better navigating Hatch-Waxman litigation.
“Highly specialized Hatch-Waxman teams have been a glaring need for pharma litigators for quite some time now,” Khatri said. “I’m excited that we’re taking major leaps towards fulfilling this need and creating unbeatable value for our clients.”
In addition to its Hatch-Waxman specialized team and playbook, BlackStone provides unique value in its technology stack with applications specifically designed for use in pharmaceutical litigation. LineOut, BlackStone’s proprietary redaction technology, redacts bulk spreadsheets and databases at an unmatchable rate of 727 spreadsheets per hour by reading cells at the row level. In Relativity, BlackStone has built in customized Hatch-Waxman workflows and coding panels to optimize the document review process. Predictive Coding can be utilized on top of Relativity using Brainspace Discovery, a powerful data analytics tool that drastically cuts the cost and time of large document reviews.
“Not only have we leveraged some of the most experienced Hatch-Waxman experts and cutting-edge technology,” BlackStone President Derek Duarte said. “But we’ve also centralized our efforts in our ISO 27001:2013 secure cloud environment that allows our teams to scale projects and add capabilities seamlessly.”
Global review centers and a review pool of 50+ US based and licensed attorneys with experience in Hatch-Waxman litigation allow BlackStone’s Hatch-Waxman division to tackle complex matters with agility. The review pool also consists of multi-lingual reviewers, which BlackStone has leveraged to deliver service to clients in the EU, India, China, and Japan. Former litigators with extensive Hatch-Waxman review experience lead the review teams, acting as liaisons between the client, counsel, the eDiscovery operations team, and the document review team.
Numerous years of in-house pharmaceutical experience have made Khatri aware of the significant need many companies have for a discovery provider with deep experience in the Hatch-Waxman arena. With the expansion of BlackStone’s specialized division, Khatri is excited to help pharmaceutical companies and litigators get ahead in Hatch-Waxman litigation.
ABOUT BLACKSTONE DISCOVERY
BlackStone Discovery is the premier legal technology and consulting provider, working with leading Fortune 500 companies and AM Law 100 firms. Since 2003, BlackStone Discovery has customized solutions for the most complex eDiscovery needs and high profile Forensic Investigations leveraging industry-leading technology and employing proprietary applications with a team of highly trained professionals. BlackStone Discovery is devoted to delivering the most cost-effective and defensible solutions available. Blackstone’s service offerings span the entire EDRM including Forensic Imaging & Internal Investigations, Relativity Hosting Solutions, Attorney Document Review, Early Data Analysis (EDA), Technology Assisted Review, Enterprise Discovery Protocols (EDP), and Case Management Consultation.